ICD-10 Coding for Follicular Lymphoma(C82.0, C82.0F, C82.0N)
Explore the ICD-10 coding for follicular lymphoma, including specific codes for different grades, documentation requirements, and common pitfalls.
Complete code families applicable to Follicular Lymphoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C82.0 | Follicular lymphoma grade I | Use when biopsy confirms grade I follicular lymphoma. |
|
| C82.1 | Follicular lymphoma grade II | Use when biopsy confirms grade II follicular lymphoma. |
|
| C82.2 | Follicular lymphoma grade III | Use when biopsy confirms grade III follicular lymphoma. |
|
| C82.9 | Follicular lymphoma, unspecified | Use when specific grade is not documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutFollicular Lymphoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Follicular Lymphoma.
Failure to document specific lymph node sites.
Impact
Clinical: Inaccurate staging and treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential for reduced reimbursement.
Mitigation
Train staff on importance of site documentation., Use templates that prompt for site details.
Confusing stage with grade in documentation.
Impact
Reimbursement: Incorrect DRG assignment can lead to reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data affecting patient records.
Mitigation
Ensure documentation specifies histologic grade, not clinical stage.
Using unspecified codes when specific grade is documented.
Impact
Reimbursement: Potential for lower reimbursement rates., Compliance: Non-compliance with specificity requirements., Data Quality: Loss of detailed clinical information.
Mitigation
Review pathology reports for specific grade and document accordingly.
Unspecified Coding
Impact
High risk of audit for using unspecified codes when specific grades are documented.
Mitigation
Implement mandatory review of pathology reports for grade documentation.